| 标题 |
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: Evaluation of Creatine Phosphokinase Elevations in the Phase 3 POETYK PSO-1 and PSO-2 Trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:SKIN The Journal of Cutaneous Medicine 作者:Mark Lebwohl; Bruce Strober; Thomas Scharnitz; Misti Linaberry; Kim Hoyt; et al 出版日期:2023 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)